396 related articles for article (PubMed ID: 19558236)
1. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.
Simeonova PP; Erdely A
Inhal Toxicol; 2009 Jul; 21 Suppl 1():68-73. PubMed ID: 19558236
[TBL] [Abstract][Full Text] [Related]
2. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma.
Frampton MW; Utell MJ; Zareba W; Oberdörster G; Cox C; Huang LS; Morrow PE; Lee FE; Chalupa D; Frasier LM; Speers DM; Stewart J
Res Rep Health Eff Inst; 2004 Dec; (126):1-47; discussion 49-63. PubMed ID: 15768531
[TBL] [Abstract][Full Text] [Related]
3. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management.
Warheit DB; Reed KL; Sayes CM
Inhal Toxicol; 2009 Jul; 21 Suppl 1():61-7. PubMed ID: 19558235
[TBL] [Abstract][Full Text] [Related]
4. Acute pulmonary effects of ultrafine particles in rats and mice.
Oberdörster G; Finkelstein JN; Johnston C; Gelein R; Cox C; Baggs R; Elder AC
Res Rep Health Eff Inst; 2000 Aug; (96):5-74; disc. 75-86. PubMed ID: 11205815
[TBL] [Abstract][Full Text] [Related]
5. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
[TBL] [Abstract][Full Text] [Related]
6. Health effects of inhaled engineered and incidental nanoparticles.
Madl AK; Pinkerton KE
Crit Rev Toxicol; 2009; 39(8):629-58. PubMed ID: 19743943
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry and toxicology of inhaled ultrafine particles.
Schmid O; Möller W; Semmler-Behnke M; Ferron GA; Karg E; Lipka J; Schulz H; Kreyling WG; Stoeger T
Biomarkers; 2009 Jul; 14 Suppl 1():67-73. PubMed ID: 19604063
[TBL] [Abstract][Full Text] [Related]
8. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
Oberdorster G
Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
[TBL] [Abstract][Full Text] [Related]
9. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics.
Johnston HJ; Hutchison GR; Christensen FM; Peters S; Hankin S; Aschberger K; Stone V
Nanotoxicology; 2010 Jun; 4(2):207-46. PubMed ID: 20795897
[TBL] [Abstract][Full Text] [Related]
10. Influence of acid functionalization on the cardiopulmonary toxicity of carbon nanotubes and carbon black particles in mice.
Tong H; McGee JK; Saxena RK; Kodavanti UP; Devlin RB; Gilmour MI
Toxicol Appl Pharmacol; 2009 Sep; 239(3):224-32. PubMed ID: 19481103
[TBL] [Abstract][Full Text] [Related]
11. Comparative pulmonary response to inhaled nanostructures: considerations on test design and endpoints.
Pauluhn J
Inhal Toxicol; 2009 Jul; 21 Suppl 1():40-54. PubMed ID: 19558233
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment.
Bergamaschi E; Bussolati O; Magrini A; Bottini M; Migliore L; Bellucci S; Iavicoli I; Bergamaschi A
Int J Immunopathol Pharmacol; 2006; 19(4 Suppl):3-10. PubMed ID: 17291399
[TBL] [Abstract][Full Text] [Related]
13. Diesel exhaust particulate (DEP) and nanoparticle exposures: what do DEP human clinical studies tell us about potential human health hazards of nanoparticles?
Hesterberg TW; Long CM; Lapin CA; Hamade AK; Valberg PA
Inhal Toxicol; 2010 Jul; 22(8):679-94. PubMed ID: 20462394
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
15. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms.
Valavanidis A; Fiotakis K; Vlachogianni T
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(4):339-62. PubMed ID: 19034792
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of human populations for early markers of cadmium toxicity: a review.
Fowler BA
Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus?
Shvedova AA; Kisin ER; Porter D; Schulte P; Kagan VE; Fadeel B; Castranova V
Pharmacol Ther; 2009 Feb; 121(2):192-204. PubMed ID: 19103221
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary and systemic effects of short-term inhalation exposure to ultrafine carbon black particles.
Gilmour PS; Ziesenis A; Morrison ER; Vickers MA; Drost EM; Ford I; Karg E; Mossa C; Schroeppel A; Ferron GA; Heyder J; Greaves M; MacNee W; Donaldson K
Toxicol Appl Pharmacol; 2004 Feb; 195(1):35-44. PubMed ID: 14962503
[TBL] [Abstract][Full Text] [Related]
19. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.
Warheit DB; Sayes CM; Reed KL; Swain KA
Pharmacol Ther; 2008 Oct; 120(1):35-42. PubMed ID: 18703086
[TBL] [Abstract][Full Text] [Related]
20. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
